Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate

Archives of Ophthalmology

Volumn 114, Issue 8, 1996, Pages 964-970

  Tolentino, Michael J ^a,b   Miller, Joan W ^a   Gragoudas, Evangelos S ^a   Chatzistefanou, Klio ^a,b   Ferrara, Napoleone ^c   Adamis, Anthony P ^a,b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; ECTROPION; EYE COLOR; EYE DISEASE; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IRIS BLOOD VESSEL; MACACA; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; TONOMETRY;

EID: 0029739620     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140172010     Document Type: Article

References (36)

1. Michaelson IC. The mode of development ot the vascular system of the retina, with some observations on its significance for certain retinal disease. Trans Ophthalmol Soc U K. 1948;68:137-180.
2. Ashton N. Retinal vascularizatior in health and disease. Am J Ophthalmol. 1957; 44:7-24.
3. Wise GN. Retinal neovascularization. Trans Am Ophthalmol Soc. 1956:54:729-826.
4. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974-3978.
5. Miller J, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/ vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994;145:574-584.
6. Adamis AP, Miller J, Bernal M, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445-450.
7. Malecaze F, Clametis S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol. 1994;112: 1476-1482.
8. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients wth diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
9. Shima D, Adamis AP, Ferrara N, et al. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med. 1995;2:64-73.
10. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92:905-909.
11. Ferrara N, Vascular endothelial growth factor: the trigger for neovascularization of the eye. Lab Invest. 1995;72:615-617.
12. Pe'er J, Shweiki D, Itin A, Memo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72:638-645.
13. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246: 1306-1309.
14. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing. Mol Endocrinol. 1991;5:1806-1814.
15. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983-985.
16. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-1312.
17. Adamis AP, Shima DT, Yeo KT, et al. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem Biophys Res Commun. 1993;193:631-638.
18. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
19. Shweiki D, Itin A, Softer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may msdiate hypoxia-initiated angiogenesis. Nature. 1992; 359:843-845.
20. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992; 359:845-848.
21. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a non-human primate. Arch Ophthalmol. 1996;114:66-71.
22. Aiello LP, Pierce EA, Foley ED, et al. Inhibition of vascular endothelial growth factor (VEGF) reduces retinal neovascularization in the mouse. Invest Ophthalmol Vis Sci. 1995;36:1865. Abstract.
23. Kim KJ, Li B, Houck K, Winer J, Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors. 1992;7:53-64.
24. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 1993;362: 841-844.
25. Ferrara N, Leung DW, Cachianes G, Winer J, Henzel WJ. Purification and cloning of vascular endothelial growth factor secreted by folliculo-stellate cells. Methods Enzymol. 1991;198:391-404.
26. Shima DT, Gougos A, Miller JW, et al. Cloning and mRNA expression of VEGF in ischemic retinas of Macaca fascicularis. Invest Ophthalmol Vis Sci. In press.
27. Tomasulo PA, Levin J, Murphy PA, Winkelstein JA. Biological activities of tritiated endotoxins: correlation of the Limulus lysate assay with rabbit pyrogen and complement-activation assay with rabbit pyrogen and complement-activation assays for endotoxin. J Lab Clin Med. 1977;89:308-312.
28. Merril CR. Gel staining techniques. Methods Enzymol. 1990;182:391-404.
29. Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology. 1993;100:9-14.
30. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol. 1989;134:733-739.
31. Sivalingam A, Kenney GC, Brown WE, Benson L, Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1990;108:869-872.
32. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest. 1993;69:508-517.
33. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun. 1992;189:824-831.
34. Danis RP, Bingaman DP, Grant M. Intravitreal insulin-like growth factor-1 induces microangiopathy in the pig retina. Invest Ophthalmol Vis Sci. 1995;36 (suppl):S1046.
35. Thieme H, Aiello LP, Takagi H, Ferrara N, King GL. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes. 1995;44:98-103.
36. Tolentino MJ, Miller JW, Gragoudas ES, et al. Vascular endothelial growth factor is sufficient to produce ocular neovascularization in a non-human primate. Invest Ophthalmol Vis Sci. 1995;36:1869. Abstract.